Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PF-614 by Ensysce Biosciences for Post-Operative Pain: Likelihood of Approval
PF-614 is under clinical development by Ensysce Biosciences and currently in Phase II for Post-Operative Pain. According to GlobalData, Phase...